NCT01173705

Brief Summary

In this project, we propose to recruit lean and obese subjects with different ethnic background (African Americans and Caucasians) to study the alterations of lipid and carbohydrate metabolism and determine whether these disturbances are linked to genetic, inflammatory, oxidative stress, and/or nutritional factors. Because systemic inflammation and insulin resistance are frequent features of obesity, we postulate that an unbalanced diet with high saturated- and low omega 3-fatty acids is linked to obesity-related inflammation and insulin resistance. We propose to investigate fatty acid metabolism and determine the links between fatty acid composition and oxidative stress in tissues of lean and obese subjects. We propose the following aims: Specific Aim 1: Evaluate nutrient intake in lean and obese subjects using the standard NHANES Food Questionnaire. Specific Aim 2: Evaluate the fatty acid composition, including omega-3, in adipose tissue depots, blood monocytes and skeletal muscle, and examine the relationship between omega-3 content and inflammatory and oxidative stress markers. Specific Aim 3: Compare the effects of omega-3 and saturated FA supplementation on inflammatory and oxidative stress markers in vitro in adipose tissue explants, preadipocytes and monocyte culture.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 2, 2010

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 20, 2017

Status Verified

January 1, 2017

Enrollment Period

2.6 years

First QC Date

July 29, 2010

Last Update Submit

January 19, 2017

Conditions

Keywords

ObesityInsulin ResistanceInflammation

Outcome Measures

Primary Outcomes (1)

  • Examine the relationship between omega-3 content and inflammatory and oxidative stress markers

    We will evaluate fatty acid composition in adipose tissues depots, blood monocytes, and skeletal muscle to examine the relationship between omega-e content and inflammatory and oxidative stress markers.

    5 years

Secondary Outcomes (2)

  • Evaluate nutrient intake

    5 years

  • Compare effects of omega-3 and saturated fatty acid supplementation on inflammatory and oxidative stress markers (in vitro)

    5 years

Study Arms (2)

Normal weight: abdominal surgery

Lean individuals undergoing elective abdominal surgery

Obese: abdominal or bariatic surgery

Obese subjects undergoing elective abdominal or bariatric surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Normal weight and obese subjects who are undergoing elective bariatric or abdominal surgery

You may qualify if:

  • years of age
  • Undergoing elective abdominal or bariatric surgery

You may not qualify if:

  • Intercurrent infections
  • Active cancer diagnosis within 5 years
  • Use of medications for diabetes or hyperlipidemia
  • Use of glucocorticoids or anti-inflammatory drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, omentum biopsy, subcutaneous fat biopsy, muscle biopsy (abdominal wall)

MeSH Terms

Conditions

ObesityInsulin ResistanceInflammation

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesPathologic Processes

Study Officials

  • Robyn Tamboli, PhD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR
  • Naji N Abumrad, MD

    Vanderbilt University Medical Center

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

July 29, 2010

First Posted

August 2, 2010

Study Start

June 1, 2011

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

January 20, 2017

Record last verified: 2017-01

Locations